Cas:675602-85-4 1-N-Tritylimidazole-2-ylpropionic acid manufacturer & supplier

We serve Chemical Name:1-N-Tritylimidazole-2-ylpropionic acid CAS:675602-85-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-N-Tritylimidazole-2-ylpropionic acid

Chemical Name:1-N-Tritylimidazole-2-ylpropionic acid
CAS.NO:675602-85-4
Synonyms:1-N-Tritylimidazole-2-ylpropionic acid
Molecular Formula:C25H22N2O2
Molecular Weight:382.45400
HS Code:2933290090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:535.7ºC at 760 mmHg
Density:1.13g/cm3
Index of Refraction:1.611
PSA:55.12000
Exact Mass:382.16800
LogP:4.74050

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-N-Tritylimidazole-2-ylpropionic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-N-Tritylimidazole-2-ylpropionic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-N-Tritylimidazole-2-ylpropionic acid Use and application,1-N-Tritylimidazole-2-ylpropionic acid technical grade,usp/ep/jp grade.


Related News: Just last week, the CDC updated J&J’s label again to warn of “an increased risk” for GBS, although the agency has maintained that a definitive link hasn’t been established. Europe’s medicines regulator added its own warning on Thursday just ahead of ACIP’s meeting. 1-(2-Methyl-allyl)-2-[1-methylsulfanyl-eth-(E)-ylidene]-cyclohexanol manufacturers GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said. 3-[3-(2-hydroxy-4-methyl-5-methoxyphenylsulphamoyl)propyl]-1-methyl-3H-imidazol-1-ium chloride suppliers “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. 3′-((4-(2-oxo-2,3-dihydrobenzo[d]oxazol-7-yl)piperazin-1-yl)methyl)-[1,1′-biphenyl]-3-carbonitrile hydrochloride vendor & factory.